Clinical Trial Update: Efficiency Evaluation of Photodynamic Therapy With Photofrin® on Unresectable Type III or IV Cholangiocarcinomas [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Photofrin-based photodynamic therapy for unresectable cholangiocarcinoma (types III/IV) has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma

Drugs mentioned

• Photofrin (porfimer sodium)

Snippet

Sponsor: University Hospital, Angers | Conditions: Cholangiocarcinoma | Phase 3 | Status: TERMINATED